Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GLAXF) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to 0.63.

  • Gsk's Asset Utilization Ratio fell 33.98% to 0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year decrease of 33.98%. This contributed to the annual value of 0.54 for FY2024, which is 520.18% up from last year.
  • Per Gsk's latest filing, its Asset Utilization Ratio stood at 0.63 for Q3 2025, which was down 33.98% from 0.64 recorded in Q2 2025.
  • Gsk's 5-year Asset Utilization Ratio high stood at 0.65 for Q4 2024, and its period low was 0.32 during Q4 2021.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.6 (2023), whereas its average is 0.53.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 2414.3% in 2021, then soared by 9760.79% in 2022.
  • Gsk's Asset Utilization Ratio (Quarter) stood at 0.32 in 2021, then skyrocketed by 97.61% to 0.62 in 2022, then dropped by 3.38% to 0.6 in 2023, then increased by 7.78% to 0.65 in 2024, then decreased by 2.51% to 0.63 in 2025.
  • Its Asset Utilization Ratio stands at 0.63 for Q3 2025, versus 0.64 for Q2 2025 and 0.65 for Q1 2025.